Posts

Showing posts with the label Recombinant Proteins Market 2030

Recombinant Proteins Market To Witness A Significant Growth Of USD 5.09 Billion By 2030

Image
  San Francisco, 5 Jan 2024:  The Report  Recombinant Proteins Market  Size, Share & Trends Analysis Report By Host Cell (Insect Cells, Mammalian), By Application (Research, Therapeutics), By Product & Services, By End-user, By Region, And Segment Forecasts, 2022 - 2030 The global recombinant proteins market size is expected to reach USD 5.09 billion by 2030, registering a CAGR of 12.0% during the forecast period, according to a new report by Grand View Research, Inc. Diseases like multiple sclerosis, neutropenia, cerebral apoplexy, anemia, and others, as well as dwarfism, are becoming more common, which is driving up the demand for recombinant protein drugs. Furthermore, the industry is anticipated to expand due to the increased development and research on biologics, which, in turn, are significantly boosting global industry growth. The focus on the development of biosimilars, biologics, and recombinant proteins has increased owing to a rise in the incidence and prevalence of

Recombinant Proteins Market Size Is Expected To Reach USD 5.09 Billion By 2030

Image
  San Francisco, 10 Aug 2023:  The Report  Recombinant Proteins Market  Size, Share & Trends Analysis Report By Host Cell (Insect Cells, Mammalian), By Application (Research, Therapeutics), By Product & Services, By End-user, By Region, And Segment Forecasts, 2022 - 2030 The global recombinant proteins market size is expected to reach USD 5.09 billion by 2030, registering a CAGR of 12.0% during the forecast period, according to a new report by Grand View Research, Inc. Diseases like multiple sclerosis, neutropenia, cerebral apoplexy, anemia, and others, as well as dwarfism, are becoming more common, which is driving up the demand for recombinant protein drugs. Furthermore, the industry is anticipated to expand due to the increased development and research on biologics, which, in turn, are significantly boosting global industry growth. The focus on the development of biosimilars, biologics, and recombinant proteins has increased owing to a rise in the incidence and prevalence of